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Synopsis 
PhCH2Mn(CO)5 reacts with 1,4-di-aryl-1-aza-1,3-butadienes in the presence of 
unsaturated substrates to give products based on a cyclomanganated intermediate. 
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2Abstract.
Reaction of PhCH2Mn(CO)5 with 1,4-di-aryl-1-aza-1,3-butadienes gave substituted 
pyrrolinonyl rings which were 4-coordinated to a Mn(CO)3 group. These are formed by 
intramolecular CO insertion into a (non-isolated) cyclomanganated intermediate, 
followed by cyclisation.  Other unsaturated reagents (PhC>CH, CH2=CHCOOMe, 
PhNCO) gave products arising from insertion of these, including a structurally 
characterised tri-aryl-5-azacyclohexadienyl-Mn(CO)3 complex from the reaction with 
the alkyne. 
1. Introduction.
Cyclomanganation of organic substrates to give complexes of the form 1 has 
proved to be a general process [1].  Substrates that have been examined include aryl- and 
hetero-aryl ketones [2] and imines [3], benzylamines [4], triphenylphosphine 
chalcogenides [5] and triphenylphosphine imines [6]. These complexes undergo a series 
of interesting reactions involving the Mn-C bond with alkenes [7], alkynes [8], organic 
isocyanates [9], sulfur dioxide [10] and carbon disulfide [11]. More recently, 
cyclomanganation studies have been extended beyond aryl substrates to reactions 
involving ,-unsaturated ketones (chalcones) where compounds of the type 2 could be 
formed [12]. These also reacted with alkynes, in particular, to give novel products, 
including 5-pyranyl- and 5-cycloheptadienyl-Mn(CO)3 derivatives [13]. 
 1-Azabutadienes, 3, are pseudo-iso-electronic with chalcones so appeared to be a 
potential source of new organomanganese chemistry. While there has been extensive use 
of azabutadienes as 4-butadiene analogues, most of the previously reported  
cyclometallated azabutadiene compounds have been prepared indirectly. These include 
3di- and tetra-ruthenium compounds [14], the di-manganese compound 4 (from 
Mn2(CO)9(CNR) and DMAD [15] ), and the manganese complex 5 (from 
ClC6H5CH2C(O)Mn(CO)4(CNC6H4CH3) and CF3CCCF3) [16]. Only some 
orthopalladiated examples 6 have involved direct cyclometallation of an azabutadiene 
[17]. 
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We now report attempts to prepare directly orthomanganated azabutadiene 
complexes, and their reactivity towards some unsaturated molecules. 
2. Experimental Section 
2.1 General 
 Electrospray mass spectra were recorded on a VG Platform II spectrometer, 
operated as detailed elsewhere [18]. Spectra were run at a cone voltage of 20 V unless 
otherwise specified, and in some cases Na[OMe] was added to provide ionisation [19]. 
NMR spectra were obtained in CDCl3 on a Bruker AC400 instrument operating under 
standard conditions, with assignments based on COSY, HSQC and HMBC experiments. 
IR spectra were recorded on a Digilab FTS-40 instrument. All reactions were carried out 
under nitrogen, but no precautions to exclude air were taken during work-up. 
4The azabutadiene 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene 3a, its 1,4-diphenyl analogue 
and PhCH2Mn(CO)5 were prepared by literature routes [20, 21]. PLC and TLC refer to 
preparative and thin layer chromatography on silica gel (Merck Kieselgel 60 PF254). 
2.2 Reactions 
2.2.1 Reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene with PhCH2Mn(CO)5.
A solution of the azabutadiene 3a (51 mg, 0.23 mmol) and PhCH2Mn(CO)5 (80 mg, 0.28 
mmol) in petroleum spirits (15 ml) was transferred to a Schlenk flask. The solution was 
heated under reflux for 6.5 hours. The solvent was removed under vacuum, and the 
residue was dissolved in dichloromethane and chromatographed (PLC), eluting with 
petroleum spirits/ether (1:1), to afford three fractions. The first fractions contained 
unreacted starting materials, while the third fraction was collected to afford the 4-1-
tolyl-3-phenyl-pyrrolin-2-onyl complex 7 which was recrystallised as yellow needles 
from diethyl ether (32 mg, 35%), m.p. 143°C. Found: C  62.03, H 3.64, N 3.62%. 
C20H14MnNO4 requires C 63.36, H 3.66, N 3.82%, M 387. (CO) (heptane) 2034(s), 
1962(m), 1945(m) cm-1. ESMS: (MeOH/NaOMe,  -ve ion) m/z 386 (4%, [M-H]-), 418 
(100%, [M+OMe]-). 1H NMR:   2.41 (3H, s, CH3), 5.98 (1H, d, 3JHH = 2.4 Hz, H4), 6.23 
(1H, d, 3JHH = 2.4 Hz, H5), 7.3 (4H, m, H2”/H3”/H5”/H6”), 7.3 (1H, t, 3JHH = 7.4 Hz, 
H4’), 7.4 (2H, dd, 3JHH = 7.5, 7.5 Hz, H3’/H5’), 7.9 (2H, d, 3JHH = 7.5 Hz, H2’/H6’); 13C
NMR :  21.4 (CH3), 71.2 (C3), 78.9 (C5), 83.1 (C4), 126.2 (C2’/C6’), 126.5 (C2”/C6”), 
127.8 (C4’), 129.1 (C3’/C5’), 130.5 (C3”/C5”), 132.2 (C1’), 132.5 (C1”), 140.1 (C4”), 
152.4 (C2), 221.5 (Mn(CO)3)
2.2.2 Reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene and PhCCH with 
PhCH2Mn(CO)5.
5A solution of the azabutadiene 3a (52 mg, 0.23 mmol), PhCCH (75 µL, 0.68 mmol) and 
PhCH2Mn(CO)5 (87 mg, 0.30 mmol) in petroleum spirits (15 ml) was heated to reflux for 
three hours. The solvent was removed under vacuum, and the residue chromatographed 
(PLC, 1:1 petroleum spirits/ether) to give three fractions. The first main fraction afforded 
the azacyclohexadienyl complex 8a which was recrystallised by vapour diffusion 
(ether/petroleum spirits) as a cream powder  (94 mg, 87%), m.p. 176°C. (CO)  
(petroleum spirits) 2025(s), 1965(m), 1946(m) cm-1. ESMS (MeOH/NaOMe, -ve ion) 
m/z 460 (27%, [M-H]-), 492 (100%, [M+OMe]-).  
1H NMR   2.22 (3H, s, CH3), 5.01 (1H, d, 3JHH = 4.2 Hz, H6), 5.52 (1H, d, 3JHH = 4.2 
Hz, H5), 6.29 (1H, s, H3), 6.58 (2H, d, 3JHH = 8.1 Hz, H2’/H6’), 6.92 (2H, d, 3JHH = 8.1 
Hz, H3’/H5’), 7.30 (1H t, 3JHH = 7.3 Hz, H4”), 7.34-7.45 (5H, m, Ar-H), 7.58 (2H, d, 
3JHH = 8.4 Hz, H2”/H6”), 7.70 (2H, d, 3JHH = 6.8 Hz, H2*/H6*);  13C NMR  20.8 (CH3), 
66.0 (C6), 82.0 (C2), 88.6 (C3), 91.7 (C5), 102.3 (C4), 115.4 (C2’/C6’), 123.9 (C2”/C6”), 
127.2 (C2*/C6*), 127.9 (C4”), 128.9 (Ar-H), 129.3 (C3’/C5’), 129.4 (Ar-H), 130.3 (C1’), 
136.9 (C1*), 138.1 (C1”), 153.1 (C4’), 221.7 (Mn(CO)3). 
The second fraction was a mixture of minor products including unreacted azabutadiene. 
The third fraction (11 mg) was manganese-free, but was not able to be characterized, 
ESMS (MeOH/NaOMe) m/z 452 (100%), 905 (27%) which can be assigned as [M-H]-
and [2M-H]- respectively for Mr = 453.  
2.2.3 Reaction of 1,4-diphenyl-1-azabuta-1,3-diene and PhCCH with PhCH2Mn(CO)5.
A petroleum spirits (30 mL) solution containing PhCH2Mn(CO)5 (160 mg, 0.56 mmol), 
diphenylazabutadiene (100 mg, 0.48 mmol) and PhCCH (200 µL, 1.96 mmol) was 
heated under reflux for four hours. The solvent was evaporated and the residue 
6chromatographed, eluting with ether/petroleum spirits (1:9). The main band was removed 
and recrystallised from hot petroleum spirits to give yellow crystals of 8b, (68 mg, 31%). 
Found: C 69.96, H 4.28, N 3.06%; C26H17MnNO3 requires 69.78, H 4.05, N 3.13%, M 
447. IR (petroleum spirits) (CO) 2023(s), 1965(m), 1946(m) cm-1. ESMS 
(MeOH/NaOMe, -ve ion) m/z 446 (20%, [M-H]-), 478 (100%, [M+OMe]-).  
1H NMR   5.01 (1H, d, 3JHH = 4.2 Hz, H6), 5.52 (1H, d, 3JHH = 4.2 Hz, H5), 6.29 (1H, s, 
H3), 6.63-7.86 (Ar-H);  13C NMR  65.3 (C6), 81.4 (C2), 88.7 (C3), 91.7 (C5), 102.4 
(C4), 115.2-155.3 (Ar-C), 221.5 (Mn(CO)3). 
2.2.4 Reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene and CH2=CHCO2Me with 
PhCH2Mn(CO)5.
A solution of the azabutadiene 3a (53 mg, 0.24 mmol), CH2=CHCO2Me (115 µL, 1.2 
mmol) and PhCH2Mn(CO)5 (79 mg, 0.28 mmol) in petroleum spirits (15 ml) was 
transferred to a Schlenk flask under nitrogen. The solution was heated to reflux for 2 
hours before the solvent was removed under vacuum. The residue was chromatographed 
(PLC, 1:1 ethyl acetate/petroleum spirits) giving three fractions. The first and last were 
minor fractions containing a mixture of products (no further purification was attempted 
on these fractions). The second fraction contained the main product 9, recrystallised as a 
yellow powder by vapour diffusion (benzene/hexane) (28 mg, 39%), m.p. 148°C.  Found 
C 63.35, H 4.73, N 3.27; C23H20MnNO3 requires C 62.03, H. 4.53, N 3.15%, M 445. 
IR (CH2Cl2) (CO) 2017(s), 1933(m, br) cm-1, (C=O) 1734 cm-1. ESMS (MeOH, +ve 
ion) m/z 308 (100%, [M-Mn(CO)3+2H]+), 468 (17%, [M+Na]+), 913 (11%, [2M+Na]+). 
1H NMR   2.23 (1H, d, 3JHH = 11.8 Hz, H2), 2.40 (3H, s, Me), 3.33 (1H, d, 3JHH = 22.3 
Hz, H5), 3.72 (1H, d, 3JHH = 22.2 Hz, H5), 3.83 (3H, s, OMe), 6.43 (1H, d, 3JHH = 11.7 
7Hz, H3), 7.04 (2H, d, 3JHH = 8.1 Hz, H2”/H6”), 7.22 (2H, d, 3JHH = 8.1 Hz, H3”/H5”), 
7.23 (1H, m, H4’), 7.39 (2H, m, H3’/H5’), 7.53 (1H, s, H6), 7.66 (2H, m, H2’/H6’); 13C
NMR   21.1 (Me), 44.7 (C5), 51.6 (OMe), 59.9 (C2), 90.5 (C4), 102.2 (C3), 120.7 
(C2”/C6”), 126.5 (C2’/C6’), 126.5 (C4’), 128.7 (C3’/C5’), 129.9 (C3”/C5”), 137.6 (C4”), 
145.7 (C1’), 150.6 (C1”), 174.7 (C1), 176.4 (C6) 
2.2.5 Reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene and PhNCO with 
PhCH2Mn(CO5.
A solution of the azabutadiene 3a (53 mg, 0.24 mmol), PhNCO (80 µL, 0.74 mmol) and 
PhCH2Mn(CO)5 (71 mg, 0.25 mmol) in petroleum spirits (15 ml) was heated to reflux for 
2 hours before the solvent was removed under vacuum. The residue was 
chromatographed (PLC, 1:4 ethyl acetate/petroleum spirits) to give four fractions, the 
first two of which were minor fractions containing unreacted starting materials. The third 
fraction was collected to afford 10 (24 mg, 30%) as a yellow solid. IR (CH2Cl2) (C=O) 
1715(br) cm-1. ESMS (MeCN, +ve ion) m/z 341 (100%, [M+H]+), 363 (45%, [M+Na]+), 
681 (43%, [2M+H]+), 703 (20%, [2M+Na]+), 1043 (8%, [3M+Na]+). 1H NMR  2.27
(3H, s, CH3), 3.90 (1H, s, NH), 6.05 (1H, d, 3JHH =2.0 Hz, H5), 6.67 (2H, d, 3JHH = 8.4 
Hz, H2’/H6’), 7.01 (2H, d, 3JHH = 8.3 Hz, H3’/H5’), 7.22 (1H, t, 3JHH = 7.4 Hz, H4”), 
7.30 (1H, d, 3JHH =2.0 Hz, H4), 7.39 (2H, m, H3”/H5”), 7.43 (2H, m, H3*/H5*), 7.46 
(1H, m, H4*), 7.58 (2H, d, 3JHH = 7.6 Hz, H2”/H6”), 7.95 (2H, d, 3JHH = 6.3 Hz, 
H2*/H6*); 13C NMR   20.8 (CH3), 70.9 (C5), 115.9 (C2’/C6’), 123.4 (C2”/C6”), 125.8 
(C4”), 127.9 (C2*/C6*), 128.9 (C3*/C5*), 129.4 (C3”/C5”), 129.5 (C4*), 129.7 (C1’), 
130.3 (C3’/C5’), 131.0 (C1*), 136.8 (C1”), 137.9 (C3), 138.2 (C4), 142.5 (C4’), 168.2 
(C2) 
8The fourth fraction afforded 11 (33 mg, 30% yield) as a dark yellow solid, m.p. = 192°C. 
IR (heptane) (C=O, C=N) 1718, 1703, 1676 cm-1. ESMS (MeOH, +ve ion) m/z 482
(100%, [M+Na]+), 941 (36%, [2M+Na]+). 1H NMR   2.35 (3H, s, CH3), 6.07 (CH), 
6.78-7.82 (Ar-H), 8.96 (NH); 13C NMR   21.5 (CH3), 67.6 (CH), 120.2-140.4 (Ar-H, 
Ar), 153.8 (C=N), 154.6 (C=O), 168.0 (C=O) 
2.2.7 Attempted reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene and ButNC with 
PhCH2Mn(CO)5.
A mixture of the azabutadiene 3a (52 mg, 0.24 mmol), ButNC (200 µL, 1.8 mmol) and 
PhCH2Mn(CO)5 (88 mg, 0.31 mmol) in petroleum spirits (15 ml) was heated to reflux for 
2 hours before the solvent was removed under vacuum. The residue was 
chromatographed (PLC, 1:1 petroleum spirits/dichloromethane) to give three fractions. 
The first fraction was unreacted azabutadiene, while the second was collected to afford 
12, recrystallised as yellow crystals from hexane (15 mg, 10% yield), m.p. 96°C. IR 
(heptane) (CN) 2135 cm-1, (CO) 1990(m), 1939(m) cm-1, (C=O), (C=N)  1713, 
1679 cm-1. ESMS (MeOH, +ve ion) m/z 480 (100%, [M+H]+). 1H NMR  1.31 (9H, s, 
But), 1.39 (9H, s, But), 1.46 (9H, s, But), 3.83 (1H, d, 2JHH = 14.1 Hz, H3), 4.27 (1H, d, 
2JHH = 14.1 Hz, H3), 7.17 (2H, m, H3’/H5’), 7.18 (1H, m, H4’), 7.23 (2H, m, H2’/H6’); 
13C NMR   29.9 (C(CH3)3), 30.6 (C(CH3)3), 31.0 (C(CH3)3), 32.7 (C3), 56.4 (C(CH3)3), 
56.9 (C(CH3)3), 59.6 (C(CH3)3), 125.7 (C4’), 128.3 (C3’/C5’), 128.7 (C2’/C6’), 138.9 
(C1’), 186.2 (C1), 194.8 (C2), 217.0, 221.5 224.4 (Mn-CO, Mn-CNBut)
ESMS determined that the third fraction contained a mixture of [Mn(CNBut)6]+ and 
[Mn(CNBut)5(CO)]+ species, and was not analysed further. 
2.2.8 Reaction of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene and CS2 with PhCH2Mn(CO)5.
9PhCH2Mn(CO)5 (81 mg, 0.284 mmol), the azabutadiene 3a (54 mg, 0.243 mmol) and 
CS2 (5 ml) were transferred to an ampoule which was sealed under vacuum. The ampoule 
was heated to 85°C in a Carius tube for 48 hours. Small yellow crystals of 13 (2 mg, 3%) 
crystallised from the cooled reaction mixture, and were identified by ESMS and IR [11]. 
TLC of the remaining reaction mixture showed a multitude of products which were not 
further investigated. 
2.3 X-ray crystallography 
X-ray intensity data were collected on a Siemens SMART CCD diffractometer using 
standard procedures and software. Empirical absorption corrections were applied 
(SADABS [22]). Structures were solved by direct methods and developed and refined on 
F2 using the SHELX programmes [23]. Hydrogen atoms were included in calculated 
positions 
2.3.1 Structure of the 4-pyrrolinonyl complex 7
Yellow needle crystals of 7 were obtained from diethyl ether. 
Crystal data: C20H14MnNO4, M = 387.26, monoclinic, space group C2/c, a = 24.314(8), b 
= 11.199(4), c = 16.664(5) Å,  = 131.33(3)°, U 3407.1(19) Å3, T 168 K, Z = 8, Dcalc = 
1.510 g cm-3, µ(Mo-K) = 0.80 mm-1, F(000) 1584;  21764 reflections collected with 2°
< 
 < 26°, 3470 unique (Rint 0.0264) used after correction for absorption (Tmax, min 0.882, 
0.686). Crystal dimensions 0.51 x 0.18 x 0.16 mm3. Refinement on F2 gave R1 0.0356 [I 
> 2 (I)] and wR2 0.0782 (all data), GoF 1.125, residual peaks (±0.26 e Å-3). The 
structure of 7 is illustrated in Figure 1, with selected bond parameters included in the 
caption to the figure. 
2.3.2 Structure of the 5-azacyclohexadienyl complex 8b
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Yellow needle crystals of 8b were obtained from petroleum spirits. 
Crystal data: C26H18MnNO3, M = 447.36, monoclinic, space group C2/c, a = 21.925(7), b 
= 10.950(4), c = 17.234(6) Å,  = 94.768(6)°, U 4123(2) Å3, T 163 K, Z = 8, Dcalc = 
1.441 g cm-3, µ(Mo-K) = 0.67 mm-1, F(000) 1840;  24528 reflections collected with 2°
< 
 < 26°, 4067 unique (Rint 0.1033) used after correction for absorption (Tmax, min 1.000, 
0.826). Crystal dimensions 0.36 x 0.18 x 0.12 mm3. Refinement on F2 gave R1 0.0416 [I 
> 2 (I)] and wR2 0.0450 (all data), GoF 0.935, residual peaks (±0.23 e Å-3). The 
structure of 8b is illustrated in Figure 2, with selected bond parameters included in the 
caption to the figure. 
 
3 Results and discussion. 
 The reactions discussed in detail below are summarised in Scheme 1. 
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3.1 Attempted cyclomanganation of 4-phenyl-1-p-tolyl-1-azabuta-1,3-diene. 
 When the azabutadiene 3a was reacted with PhCH2Mn(CO)5, under the refluxing-
heptane conditions used successfully for cyclometallation of chalcones, a yellow product 
was readily isolated.  Elemental analysis and ESMS were consistent with the expected 
product, a cyclometallated azabutadiene, but the infrared spectrum was not since the 
(CO) pattern was more like that of a Mn(CO)3 moiety than the characteristic Mn(CO)4
type. 
 An X-ray crystal structure determination was therefore carried out.  This showed 
that a substituted pyrrolinonyl ring had formed and was coordinated to a Mn(CO)3 group 
as in 7. The structure is illustrated in Figure 1.   
[Figure 1 near here] 
Clearly the deprotonated azabutadiene group has combined with a CO ligand to form the 
new planar ring structure, and this acts as a five-electron donor to the manganese, with 
two electrons from the N atom, two from the C(4)-C(5)  bond, and one from C(6). This 
leaves the C=O group free of interaction with the manganese atom, although the 
Mn...C(7) is quite short (2.375 Å). 
 There appear to be no previous examples of 4- pyrrolinonyl complexes, the closest 
analogues being some 2-pyrrolinone-Fe(CO)4 species [24]. This new synthesis of 
pyrrolinonyl rings is of interest as such five-membered rings are involved in several areas 
of organic chemistry [25], and different substituents could be incorporated by choosing 
the appropriate azabutadiene. 
12
A route to complex 7 can be proposed, by analogy with chalcone chemistry 
(Scheme 2) [13].  
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The first step is presumably to form the cyclometallated azabutadiene 5b. Under the 
conditions, and in contrast to chalcone examples, there is rapid insertion of a CO ligand 
into the Mn-C -bond. Addition of the new Mn-C bond across the N=C bond forms the 
five-membered ring with the Mn(CO)3 group attaching to one face in a 4 manner to 
achieve an eighteen-electron configuration. 
 To investigate the reaction in more detail, it was repeated under milder conditions 
with monitoring by IR spectroscopy. When a mixture of the azabutadiene and 
PhCH2Mn(CO)5 was slowly heated in heptane, no change was observed until the 
temperature of the oil bath reached 70°C, at which time two new IR peaks appeared at 
2034 and 2076 cm-1. The former of these can be attributed to the pyrrolinonyl complex 7,
while the latter is in the position expected for the highest frequency v(CO) band for the 
13
cyclometallated azabutadiene 5b (c.f. ~2080 cm-1 for cyclomanganated chalcones [12]).  
As the reaction continued the 2034 cm-1 peak increased, while that at 2076 cm-1 was 
never more than a small feature.  This is consistent with the process in Scheme 2, where 
the cyclomanganated azabutadiene is formed, but rapidly reacts further by CO insertion. 
3.2 Reaction in the presence of PhCCH. 
 Although the cyclomanganated complex 5b could not be isolated, its reactivity in 
situ with other substrates was of interest. Several groups have shown that reactions 
between cyclomanganated aryl ketones or chalcones and alkynes proceed via 
insertion/cyclisation processes to give novel derivatives [8, 13], so the corresponding 
reaction was investigated here. When a mixture of the azabutadiene 3a, PhCH2Mn(CO)5
and PhCCH (ca 1:1:3) was heated in petroleum spirits a reaction occurred to give a 
solution with v(CO) peaks indicative of a Mn(CO)3 group, but shifted ~10 cm-1 to lower 
frequencies compared with those of the pyrrolinonyl-complex 7. Work-up provided two 
products. The major one was identified spectroscopically as the 5-azacyclohexadienyl 
complex 8a formed in excellent yield.  
Mn(CO)3
N PhPh
8b
Ph
 
This is the N-analogue of the 5-pyranyl complexes formed when cyclomanganated 
chalcones are reacted with alkynes [13], and a similar route can be assumed. This invokes 
the cyclomanganated azabutadiene 5b as the first intermediate, which undergoes insertion 
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of PhCCH into the Mn-C bond. Cyclisation involving the N=C bond leads to the six-
membered ring with the Mn(CO)3 group occupying one face (Scheme 3).  
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The minor product from the reaction of the azabutadiene with PhC>CH was not 
identified, but appears to have arisen from CO insertion and double addition of PhC>CH 
to give a species which the mass spectrum suggests has an Mr of 453. 
 Compounds analogous to 8 have been prepared previously by reactions of alkynes 
with RC6H4CH2C(O)Mn(CO)4(CNC6H4R'), probably via a cyclomanganated 
azabutadiene formed in situ by coupling the isonitrile with the first equivalent of alkyne 
[16].  Interestingly, the azacyclohexadienyl ligands found in that study were either 4 or 
5, depending on the substituents. These cannot be distinguished reliably by 
spectroscopic means, but it seemed probable that 8a contained an 5 ligand in the absence 
of electron-withdrawing substituents on the ring. We could not prepare crystals of 8a
suitable for X-ray crystallography to confirm this, so the corresponding reaction using 
1,4-diphenyl-1-azabutadiene was carried out. This gave 8b in a completely analogous 
15
procedure and this compound crystallised well. The structure of 8b is shown in Figure 2 
and confirms the 5-attachment of the ligand to the manganese.  
[Figure 2 near here] 
The C(1)-C(5) atoms are planar to within ±0.024 Å, forming a dihedral angle with the 
C(1)-N(1)-C(5) plane of 50°. The Mn-C bond distances range from 2.107(2)-2.202(3) Å, 
average 2.146 Å, which indicates slightly stronger bonding of the ring than in the related 
(5-pyranyl)Mn(CO)3 complexes where the average Mn-C distance was 2.188 Å [13].  
The structure of 8b is directly comparable to the 5-azacyclohexadienyl examples with 
other substituents reported by Homrighausen et al [16]. 
3.3 Reaction in the presence of CH2=CHCOOMe. 
Activated alkenes are also known to react with cyclomanganated substrates derived 
from aryl ketones and chalcones [7, 13]. A mixture of the azabutadiene 3a,
PhCH2Mn(CO)5 and CH2=CHCOOMe reacted to give one main product which was 
characterised spectroscopically as 9 in moderate yield. ESMS and elemental analysis 
confirmed the formula as a combination of one CH2=CHCOOMe, one deprotonated 
azabutadiene molecule and one Mn(CO)3 fragment, while IR data confirmed a Mn(CO)3
unit and showed from the (C=O) at 1734 cm-1 that the carboxylate group was not 
coordinated to the metal. A peak at 1699 cm-1 can be assigned to a non-conjugated C=N 
bond. This information, and a full 2-D NMR study, leads to the structure 9, in which the 
CH2=CHCOOMe has coupled to the azabutadiene through C-4 to give a disubstituted 
methyl 7-azahepta-3,6-dien-2-yloate ligand. This is coordinated to the Mn(CO)3 group 
via an 3-allyl interaction, with the remaining two electrons coming from the N atom.  
Again the formation of this species can be explained by initial formation of the 
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cyclomanganated complex 5b, followed by insertion of the alkene into the Mn-C bond 
and subsequent rearrangement giving the product. When an orthomanganated chalcone 
was reacted with CH2=CHCOOMe in CCl4 the main product was a substituted methyl 7-
oxo-hepta-2,6-dienoate, which is the protio-demetallated equivalent of 9 [12]. 
3.4 Reaction in the presence of PhNCO. 
Liebeskind and co-workers reacted orthomanganated substrates with PhNCO and showed 
that insertion followed by cyclisation led to phthalimidines [9]. In the present system, 
PhNCO with PhCH2Mn(CO)5 and the azabutadiene gave two organic products, both in 
about 30% yield. The first of these showed an [M+H]+ peak at m/z 341 in the ESMS, 
giving a mass of 340 which corresponds to a combination of one PhNCO and one 
azabutadiene molecule. The IR spectrum showed a peak at 1715 cm-1 assigned to a free 
C=O group, and the NMR spectra were consistent with the structure 10. This can be 
explained by an insertion of PhNCO into the Mn-C bond of 5b, followed by cyclisation 
involving the imine carbon atom to give a five-membered ring.  Subsequent protio-
demetallation would give 10.
The other product from the reaction was shown to have a mass of 459 from ESMS. This 
equates to a combination of one azabutadiene molecule with two PhNCO molecules, 
presumably via a double insertion process. The IR spectrum contained three peaks in the 
C=O or C=N region. A possible structure is shown (11) but this could not be confirmed 
from NMR data so should be regarded as a tentative assignment only. 
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3.5 Reaction in the presence of ButNC or CS2.
These substrates were also examined as "one-pot" reagents. However in neither 
case were products derived from the azabutadiene isolated.  ButNC gave a low yield of a 
complex 12 which is not unexpected from a reaction between PhCH2Mn(CO)5 and an 
isonitrile, based on other studies of RMn(CO)5 compounds with isonitriles [26]. The 
formation of 12 involves stepwise insertion of first a CO ligand and secondly a ButNC 
one, with further replacement of two terminal carbonyl groups by isonitriles. (An isomer 
of 12 with the inserted CO and ButNC interchanged cannot be excluded 
spectroscopically, but is less likely.)  It appears that isonitriles are too effective as Lewis 
bases and react with PhCH2Mn(CO)5 before the reaction with the azabutadiene to form 
5b can take place. 
 In a rather unspecific reaction, CS2 gave a low yield of the trithiocarbonate-
tetramanganese compound 13, which has been found in similar reactions with other 
cyclomanganated substrates [11].   
3.6 Summary 
 Although no cyclomanganated azabutadiene derivative 5b could be isolated, it 
appears that this is the first-formed compound in the reaction of 3a with PhCH2Mn(CO)5.
This provides an activated form of the azabutadiene for subsequent coupling. A survey of 
"one pot" reactions between an azabutadiene and unsaturated substrates in the presence of 
PhCH2Mn(CO)5 shows that useful new compounds can be formed. 
 It is interesting that the three unsaturated molecules PhCCH, CH2=CHCOOMe 
and PhNCO all appear to insert initially into the Mn-C bond of a pre-formed 5b to give a 
seven-membered metallocyclic ring intermediate, but that reactions then proceed 
18
differently. The alkyne-intermediate cyclises by attack at the imine nitrogen atom to give 
a six-membered ring, the PhNCO-intermediate attacks at the imine carbon atom to give a 
five-membered ring, while the alkene-derived species does not undergo a cyclisation 
reaction at all.  Further work with other azabutadienes and other unsaturated molecules 
are underway to determine the factors that affect this reactivity. 
 
4. Supplementary material. 
Crystallographic data for the structural analyses have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC nos 237998 and 237999. Copies of this information 
may be obtained free of charge from the Director, CCDC, 12 Union Rd., Cambridge CB2 
1EZ, UK (Fax: +44-1223-336033; e-mail: deposit@ccdc.cam.ac.uk or www: 
http://www.ccdc.cam.ac.uk). 
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Captions to figures. 
 
Figure 1.  The structure of the 4-1-tolyl-3-phenylpyrrolin-2-onyl-manganese 
tricarbonyl complex 7.
Bond lengths include: Mn(1)-N(1)  2.102(2), Mn-C(4)  2.080(2), Mn-C(5) 
2.131(2), Mn-C(6) 2.195(2), Mn...C(7) 2.375(2) , C(7)-O(4) 1.214(2), C(4)-
C(5) 1.394(3), C(5)-C(6) 1.421(3) Å. 
 
Figure 2. The structure of the 1, 2, 4-triphenyl-1-azacyclohexa-2,4-dien-6-yl-
manganese tricarbonyl complex 8b. Bond lengths include: Mn(1)-C(1) 
2.202(2) , Mn-C(2) 2.121(2),  Mn-C(3) 2.160(3), Mn-C(4) 2.107(3), Mn-
C(5) 2.142(3), C(1)-N(1) 1.453(3), C(5)-N(1) 1.429(3), C(11)-N(1) 
1.420(3)Å. 
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